Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy-Reference-Cited by-同舟云学术

Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy

Published:2021-11 Issue:18 Volume:78 Page:1800-1813
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Goldman Adam,Maor Elad,Bomze David,Liu Jennifer E.,Herrmann Joerg,Fein Joshua,Steingart Richard M.,Mahmood Syed S.,Schaffer Wendy L.,Perales Miguel-Angel,Shouval Roni

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Chimeric antigen receptor therapy;June;N Engl J Med,2018

2. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N Engl J Med,2017

3. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med,2019

4. Outcomes in refractory diffuse large B-cell lymphoma: Results from the international SCHOLAR-1 study;Crump;Blood,2017

5. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N Engl J Med,2018

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy;Hematology, Transfusion and Cell Therapy;2024-09

2. Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention;Frontiers in Immunology;2024-08-26

3. The cardiotoxic effects of CAR‐T cell therapy: An updated systematic review and meta‐analysis;European Journal of Haematology;2024-08-22

4. Cardiac adverse events after Chimeric Antigen Receptor (CAR) T cell therapies: an updated systematic review and meta-analysis;Cardio-Oncology;2024-08-20

5. Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study;Pharmaceuticals;2024-08-05